Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
INVA
#2051
Innoviva, Inc. Common Stock
24.190
0
USD
+0.92%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.92%
Aylık Değişim
+9.01%
6 aylık değişim
+35.75%
Yıllık Değişim
+35.75%
Önceki Kapanış
23.970
0
Open
24.190
0
Bid
Ask
Low
24.190
0
High
24.190
0
Hacim
108
Piyasalar
ABD Borsası
Sağlık Hizmetleri
INVA
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
101.39 M
69.57 M
68.13 M
63.23 M
62.68 M
74.07 M
—
Valuation ratios
Enterprise value
1.46 B
1.5 B
1.06 B
1.29 B
1.04 B
1.2 B
4.55 B
Price to earnings ratio
6.13
6.01
5.6
7.44
48.19
6.06
38.18
Price to sales ratio
4.18
4.15
3.81
4.58
3.59
4.12
14.71
Price to cash flow ratio
4.49
4.47
6.27
10.08
6.82
8.6
28.36
Price to book ratio
2.61
3.92
2.23
2.11
1.86
1.44
2.86
Enterprise value to EBITDA ratio
3.22
2.85
2.08
3.86
11.96
3.15
19.34
Profitability ratios
Return on assets %
0.29
0.4
0.18
0.14
0.02
0.17
0.17
Return on equity %
0.48
0.7
0.39
0.27
0.03
0.23
0.25
Return on invested capital %
190.66
169.27
82.42
59.28
50.64
53.61
66.58
Gross margin %
100
100
100
100
100
74.8
301.72
Operating margin %
95.35
95.72
66.64
50.42
56.72
39.81
161.45
EBITDA margin %
99.46
99.25
88.91
70.2
18.23
71.86
304.44
Net margin %
87.24
94.12
66.48
57.89
6.52
65.92
237.58
Liquidity ratios
Quick ratio
—
—
2.87
7.96
2.21
13.85
31.93
Current ratio
55.98
54.02
3.29
9.03
2.35
14.64
33.89
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.39
0.41
0.31
0.25
0.28
0.28
0.3
Solvency ratios
Debt to assets ratio
0.39
0.43
0.36
0.36
0.2
0.16
0.75
Debt to equity ratio
0.71
0.95
0.79
0.67
0.37
0.23
1.25
Long term debt to total assets ratio
0.39
0.43
0.36
0.36
0.2
0.16
0.74
Long term debt to total equity ratio
0.71
0.95
0.79
0.66
0.37
0.22
1.23
Per share metrics
Operating cash flow per share
2.76
3.86
2.12
1.62
2.54
2.32
2.53
EBIT per share
2.83
3.98
3.01
2.23
0.5
3.15
3.39
EBITDA per share
2.95
4.12
3.09
2.51
0.88
3.49
3.98
Total debt per share
3.4
4.18
4.7
5.17
3.49
3.17
13.42
Cash per share
2.17
2.14
3.06
2.23
4.11
6.5
21.9
Net current asset value per share
3.01
3.33
4.66
3.96
7.47
8.58
33.64
Tangible book value per share
4.75
4.4
3
4.91
6.27
11.48
33.68
Working capital per share
2.96
3.26
3.24
3.52
4.29
8
25.82
Book value per share
4.75
4.4
5.94
7.77
9.32
13.84
44.5
Haberler
Cantor Fitzgerald, Innoviva hissesi için tavsiyesini korudu
AI Play Analog Devices Leads 14 Top Performers Onto These Best Stock Lists
Analysts See This Pharma Stock Surging 60%; Eyes Fresh Entry
Aris Mining Stock, Franco-Nevada, HSBC Among 30 New Stocks On IBD Watchlists
Oil Major EQT Pops To Record High, Leads 23 Hot Names New To Best Stock Lists
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts - TipRanks.com
Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists
Cantor Fitzgerald, Inova Technology hisse hedefini yükseltti
Cantor Fitzgerald raises Inova Technology stock price target on earnings beat
Stocks Showing Market Leadership: United Therapeutics Earns 91 RS Rating
Stocks Showing Market Leadership: United Therapeutics Earns 91 RS Rating
Celldex Therapeutics Stock Earns 88 RS Rating